Type : Contract
ILLUMINA NEXTSEQ REAGENT KITS Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Thu Dec 22 18:00:00 GMT 2022
ILLUMINA NEXTSEQ REAGENT KITS Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Thu Dec 22 18:00:00 GMT 2022
ILLUMINA INC:1107104 [21-002130] - THE GENOME ANALYZER CORE FACILITY WITHIN NIAMS REQUESTS THE PURCHASE OF SEQUENCING REAGENT KITS FOR OUR ILLUMINA NOVASEQ 6000 AND NEXTSEQ 550. THESE KITS ARE EXTREME... Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Tue Sep 02 17:00:00 GMT 2025
Purpose or Objective: Purchase of NextSeq 500/550 v2.5 sequencing reagent kits.4. Period of Performance: 7/30/22 to 7/29/23.5. CONTRACTOR REQUIREMENTSScope of Work:This is a standing order with multi-type of sequencing kits and reagents as all those kits and reagents with very short shelf life.
The need is for Control Software upgrades (20038658) and Preventative Maintenance Service (SP-103-1004) on two MiSeq’s, Control Software upgrade (20038659) on one NextSeq, and a service contract on one iSeq (20023959). MiSeq, NextSeq, and iSeq are manufactured by Illumina, Inc. Additionally, MiSeq reagents kits (MS-102-3003, qty 30, delivered at two time points, 2 months apart, and FC-131-1096, qty 1) are required.
The need is for Control Software upgrades (20038658) and Preventative Maintenance Service (SP-103-1004) on two MiSeq’s, Control Software upgrade (20038659) on one NextSeq, and a service contract on one iSeq (20023959). MiSeq, NextSeq, and iSeq are manufactured by Illumina, Inc. Additionally, MiSeq reagents kits (MS-102-3003, qty 30, delivered at two time points, 2 months apart, and FC-131-1096, qty 1) are required.
.: 20024908 Description: NextSeq 500/550 High Output Kit v2.5 (300 Cycles) Illumina, Inc. is the sole manufacturer of the NextSeq 500/550 v2.5 sequencing reagent kits used in CAR-T cells manufacturing and the only reagents compatible with the bench top Illumina NextSeq 550 Sequencer system. Other manufacturer reagents are not compatible with the Illumina NextSeq 550 Sequencer system.
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Illumina, Inc. to purchase reagent kits for use with the Illumina MiSeq and NextSeq instruments.This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1).